• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Providence Ventures Closes $150M Fund to Foster Healthcare Innovation

by Fred Pennic 01/09/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Providence Ventures Closes $150M Fund to Foster Healthcare Innovation

Providence Ventures, the Venture capital arm of Providence St. Joseph Health (PSJH) has announced a second $150 million healthcare venture capital and growth equity fund. Founded in 2014, Providence Ventures manages $300 million in venture capital funds on behalf of Providence St. Joseph Health (PSJH), the nation’s third-largest health system.  

Providence Ventures Second Health Fund Focus Areas

Providence Venture’s investment strategy is focused on identifying the best opportunities that align with the interests of their portfolio companies and the innovation priorities of Providence St. Joseph Health (PSJH), through broad solution deployment and strategic insight. The second fund will focus on investing in early and growth-stage healthcare companies that specialize in healthcare information technology, technology-enabled services, medical devices, and healthcare services. 

In addition, the fund will invest $5 to $15 million per Portfolio Company with the flexibility to lead investment rounds or participate as a syndicate partner. To date, Providence Ventures has invested in fifteen portfolio companies and co-invested with over twenty-five leading healthcare venture capital firms. 

“Providence Ventures’ investment model is to find and invest in companies that create needle-moving opportunities that address top priorities for PSJH,” said Aaron Martin, Providence Ventures’ Managing General Partner, who also serves as Providence St. Joseph Executive Vice President and Chief Digital Innovation Officer. “We partner closely with teams at PSJH and our portfolio companies to iterate, test, and scale their solutions at PSJH and other partner health systems. As evidence of the success of this model, all fifteen of our portfolio companies have commercial agreements with us, including several which have expanded enterprise-wide since our initial investment.”

Growth Plans for 2019 

Recently the team leadership has expanded to include David Kereiakes, Partner, and Rich Proscia, Senior Associate. Kereiakes is an experienced healthcare investor who most recently joined Providence Ventures from River Cities Capital Funds.  Proscia joined the team from CVS, and prior to that Athenahealth, where he worked on venture investment initiatives. The team will be expanding further with additional hires planned in early 2019. 

Providence Ventures portfolio companies include Avia, Binary Fountain, Collective Medical Technologies, Kyruus, Lyra Health, Omada Health, Trilliant Health, and more.  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Health IT Venture Capital, healthcare innovation, healthcare innovation fund, Providence Ventures, venture capital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |